|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Napo Pharmaceuticals, Inc.
| | | Phone: | (844) 722-8256 | Year Established: | 2001 | Ticker: | JAGX | Exchange: | NASDAQ | Main Contact: | Lisa Conte, CEO & Founder | | Company Description | Napo Pharmaceuticals, a wholly-owned subsidiary of Jaguar, is focused on the development and commercialization of proprietary pharmaceuticals from rainforest resources for the global marketplace in collaboration with local partners. Recently, Napo and Jaguar Animal Health, an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses, announced plans for a proposed merger of the two companies.
On Feb. 8, 2017, Jaguar Animal Health and Napo Pharmaceuticals announced they had completed the merger the two companies. As of Oct. 1, 2016, Napo owned 22.6% of Jaguar’s outstanding shares of common stock. Napo will operate as a wholly-owned subsidiary of Jaguar, focused on human health. | |
|
|
|
|
|